Basic and Diluted Loss Per Share - Schedule of Anti-dilutive Financial Instruments (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Options [Member] | ||
| Schedule of Anti-dilutive Financial Instruments [Line Items] | ||
| Anti-dilutive shares | 1,923,681 | 519,335 |
| Warrants [Member] | ||
| Schedule of Anti-dilutive Financial Instruments [Line Items] | ||
| Anti-dilutive shares | 18,235,515 | 12,646,131 |
| Contingent Shares [Member] | ||
| Schedule of Anti-dilutive Financial Instruments [Line Items] | ||
| Anti-dilutive shares | 200,000 | 200,000 |
| Redeemable Convertible Preferred Shares [Member] | ||
| Schedule of Anti-dilutive Financial Instruments [Line Items] | ||
| Anti-dilutive shares | 14,773,500 | 25,688,700 |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|